FDA.reportPublic FDA data

levothyroxine sodium anhydrous

RxCUI
1372638
RxNorm name
levothyroxine sodium anhydrous
Term type
PIN
Status
Active
Updated
2026-11-04 11:52:12

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
042013
Active start
042013
Multiple ingredient
NO
Branded
NO

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
levothyroxine10582

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRlevothyroxine sodium anhydrous1NAMES
RxNorm Namelevothyroxine sodium anhydrous1NAMES
TTYPIN1ATTRIBUTES
SPL_SET_ID
21 linked values
21CODES
UNII_CODE054I36CPMN1CODES
RxCUI13726381CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 7 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSONESOURCE SPECIALTY PHARMA LIMITEDae9954a5-e196-449c-abea-ebe4afbee5172026-08-12Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFosun Pharma USA Inc.3361138a-6e6f-e8df-e063-6294a90af2de2025-05-05Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSENDO USA, Inc.9d815416-11c9-470e-a82f-89b0bf232e122025-04-28Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLCce990712-49c1-4f66-9ee4-c770e8ec394c2025-04-17Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLC152d071f-d4aa-46d2-b397-61c1cabdd86d2024-10-14Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSFresenius Kabi USA, LLCf88f44d8-2f18-4155-9d78-6323d19fbafe2024-10-14Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS
Levothyroxine SodiumLEVOTHYROXINE SODIUM ANHYDROUSSagent Pharmaceuticalsf57e9b19-6f17-4520-80fc-511322cc56c92023-10-19Boxed warning, Warnings, Adverse reactionsName fallback
generic name: LEVOTHYROXINE SODIUM ANHYDROUS

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLD013974ThyroxineCHEMhas_chemical_structurelevothyroxine
FDASPLN0000175945l-ThyroxineEPChas_epclevothyroxine
MEDRTD013974ThyroxineCHEMhas_ingredientlevothyroxine
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine sodium anhydrous
MEDRTD000309Adrenal InsufficiencyDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine
MEDRTD004342Drug HypersensitivityDISEASEci_withlevothyroxine sodium anhydrous
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine sodium anhydrous
MEDRTD006042GoiterDISEASEmay_treatlevothyroxine
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine sodium anhydrous
MEDRTD007037HypothyroidismDISEASEmay_preventlevothyroxine
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine sodium anhydrous
MEDRTD009203Myocardial InfarctionDISEASEci_withlevothyroxine
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine sodium anhydrous
MEDRTD009230MyxedemaDISEASEmay_treatlevothyroxine
MEDRTD013959Thyroid DiseasesDISEASEmay_diagnoselevothyroxine
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine sodium anhydrous
MEDRTD013964Thyroid NeoplasmsDISEASEmay_treatlevothyroxine
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine sodium anhydrous
MEDRTD013967Thyroiditis, AutoimmuneDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine sodium anhydrous
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine sodium anhydrous
MEDRTD013971ThyrotoxicosisDISEASEmay_treatlevothyroxine
MEDRTD013971ThyrotoxicosisDISEASEci_withlevothyroxine
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine sodium anhydrous
MEDRTN0000000237Thyroid Hormone Receptor AgonistsMOAhas_moalevothyroxine
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine sodium anhydrous
MEDRTN0000008347Cellular Synthetic Activity AlterationPEhas_pelevothyroxine
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine sodium anhydrous
MEDRTN0000009340Increased GluconeogenesisPEhas_pelevothyroxine
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine sodium anhydrous
MEDRTN0000009399Increased Metabolic RatePEhas_pelevothyroxine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
CODESSNOMEDCT783637002
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceUS Edition of SNOMED_CT